Paul Mampilly The Great American Investment Manager

Paul Mampilly is an investor and former hedge fund manager. He is also a recipient of the prestigious Templeton Foundation investment challenge.

Because of his investment successes, Mampilly has been featured by leading business media groups including Fox Business News, Bloomberg TV, and CNBC. To this end, Paul has had a great track record managing his personal and corporate investment accounts.

Paul is also the founder of the Profits Unlimited a popular investment newsletter. He makes use of his experience, skills as well as knowledge to give his over 90, 000 subscribers the insider tips in Wall Street about stocks which they can invest in for profits.

Currently, Paul lives in the United States but was born in India. He migrated to the United States where he started his career on Wall Street. He began his Wall Street career in 1991 working for Bankers Trust as an assistant portfolio manager. Since then he has held prominent positions in large investment firms such as ING and Deutsche Bank. He has managed multi-million dollar accounts earning lots of profits.

In his career as an investor, he has also managed funds for the Sears, Royal Bank of Scotland, as well as a Swiss bank. Due to his skills and experience about Wall Street, Paul was recruited by Kinetics Asset Management owners. He became one of the key managers of the $6 billion company. Under his leadership, the hedge fund’s assets rose to $25 billion.

The huge returns realized by the hedge fund eventually made Barron to name it among the best hedge funds in the world. As such, the hedge fund realized average annual returns of 26% throughout Paul’s tenure. As a result, the Templeton Foundation invited Paul to participate in a prestigious investment competition.

After the competition, Paul managed a return of 76% in only one year. He has managed to grow an investment of $50 million to $ 88 million within a year. It should be noted that he managed to realize these returns at the time when the world market was crushing in 2008 and 2009.

In 2012 Paul invested in the Sarepta Therapeutics an organization in its early days of developing a drug used in treating muscular dystrophy. After only 8 months, he sold his shares in the company making a 2, 539% gain. Additionally, in 2008 he invested in Netflix as he saw traditional TVs being replaced by the online video streaming websites. When he sold his investment in Netflix in 2010, he made a 634% gain.